Related Experiment Video

Updated: May 6, 2026

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

13.4K

Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists

Victoria Vinader1, Djevdet S Ahmet, Mohaned S Ahmed

  • 1Institute of Cancer Therapeutics, University of Bradford, Bradford, United Kingdom.

Plos One
|November 9, 2013
PubMed

Insights

Researchers identified new small molecule CXCR4 antagonists to combat cancer metastasis. These compounds target the CXCL12/CXCR4 pathway, crucial in cancer cell migration and linked to poor prognosis in several cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • The CXCL12/CXCR4 chemokine axis is a key driver of cancer cell migration and metastasis.
  • High expression of CXCR4 in tumors correlates with poor patient prognosis across various cancers, including lung, brain, CNS, blood, and breast cancers.

Purpose of the Study:

  • To identify and develop a novel class of small molecule antagonists targeting the CXCR4 receptor.
  • To investigate the efficacy of these antagonists against CXCL12-induced cancer cell functions.

Main Methods:

  • Utilized computational modeling for rational drug design.
  • Synthesized new small molecule compounds.
  • Determined in vitro activity against CXCL12-induced intracellular calcium mobilization, proliferation, and chemotaxis.

Main Results:

  • Identified a new class of small molecule CXCR4 antagonists.
  • Computational modeling successfully rationalized observed compound potencies.
  • In vitro assays confirmed antagonist activity against key cancer cell migration pathways.

Conclusions:

  • Small molecule CXCR4 antagonists represent a promising therapeutic strategy for inhibiting cancer metastasis.
  • Integrated computational and experimental approaches are effective for discovering potent drug candidates targeting chemokine pathways.

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.5K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129